Cefmetazole

규격

56796-20-4CAS 번호

260-384-2EC 번호

(6R,7S)-7-[[2-(cyanomethylsulfanyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acidIUPAC 명칭

C15H17N7O5S3화학식

471.5 g/mol분자량

cefmetazole; 56796-20-4; Cefmetazolo; Cefmetazolum; (6R,7S)-7-[[2-(cyanomethylsulfanyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cefmetazol; 3J962UJT8H; CHEBI:3489; U-72791; DTXSID7022756; (6R,7S)-7-({[(cyanomethyl)sulfanyl]acetyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((((cyanomethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-cis)-; (6R,7S)-7-{2-[(cyanomethyl)sulfanyl]acetamido}-7-methoxy-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7S)-7-((((cyanomethyl)sulfanyl)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)sulfanyl)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7S)-7-((2-(cyanomethylsulfanyl)acetyl)amino)-7-methoxy-3-((1-methyltetrazol-5-yl)sulfanylmethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7S)-7-(2-((cyanomethyl)sulfanyl)acetamido)-7-methoxy-3-(((1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; RefChem:574974; DTXCID502756; J01DA40; 260-384-2; CS1170; Cefmetazolum [INN-Latin]; Cefmetazolo [INN-Spanish]; MFCD00865068; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[[(cyanomethyl)thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, (6R,7S)-; (6R,7S)-7-(2-((Cyanomethyl)thio)acetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7S)-7-(2-((Cyanomethyl)thio)acetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; SKF 83088; CS 1170; C15H17N7O5S3; U 72791; Cefmetazole (USP/INN); EINECS 260-384-2; BRN 0634647; UNII-3J962UJT8H; Cefmetazole [USAN:USP:INN]; (6R,7S)-7-[2-[(Cyanomethyl)thio]acetamido]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 56796-20-4 (free); CefmetaZole, 95%; CEFMETAZOLE [MI]; Prestwick0_000700; Prestwick1_000700; Prestwick2_000700; Prestwick3_000700; CEFMETAZOLE [INN]; CEFMETAZOLE [USAN]; Epitope ID:116204; CEFMETAZOLE [VANDF]; CEFMETAZOLE [MART.]; CS 1170;SKF 83088;U 72791;U 72791a; Lopac0_000266; BSPBio_000859; CEFMETAZOLE [USP-RS]; CEFMETAZOLE [WHO-DD]; SCHEMBL147832; SPBio_002780; BPBio1_000945; orb1710132; CEFMETAZOLE SODIUM [JAN]; CHEMBL1201195; GTPL12215; MSK2846; SNBUBQHDYVFSQF-HIFRSBDPSA-N; CEFMETAZOLE [USP IMPURITY]; CEFMETAZOLE [USP MONOGRAPH]; HY-B1595; BDBM50350471; EBC-27178; T1070L; AKOS015896219; DB00274; SDCCGSBI-0050254.P002; (6R,7S)-7-({[(cyanomethyl)thio]acetyl}amino)-7-(methyloxy)-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7S)-7-(2-((Cyanomethyl)thio)acetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, sodium salt; AC-13154; BS-42476; CS-0013513; NS00011557; C08103; D00910; EN300-19766367; -1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Q5057238; BRD-K48470486-236-10-8; (6R,7S)-7-({[(cyanomethyl)sulfanyl]acetyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia; (6R,7S)-7-{2-[(Cyanomethyl)sulfanyl]acetamido}-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(cyanomethyl)sulfanyl]acetamido}-7alpha-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}ceph-3-em-4-carboxylic acid동의어